SEED Co.,Ltd. (TYO:7743)
Japan
· Delayed Price · Currency is JPY 534.00
+5.00 (0.95%)
Mar 10, 2026, 9:50 AM JST
SEED Co.,Ltd. Revenue
SEED Co.,Ltd. had revenue of 8.38B JPY in the quarter ending December 31, 2025, with 0.23% growth. This brings the company's revenue in the last twelve months to 33.57B, up 0.33% year-over-year. In the fiscal year ending March 31, 2025, SEED Co.,Ltd. had annual revenue of 33.23B with 2.58% growth.
Revenue (ttm)
33.57B
Revenue Growth
+0.33%
P/S Ratio
0.48
Revenue / Employee
34.08M
Employees
985
Market Cap
16.01B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 33.23B | 835.00M | 2.58% |
| Mar 31, 2024 | 32.40B | 1.80B | 5.89% |
| Mar 31, 2023 | 30.59B | 1.76B | 6.10% |
| Mar 31, 2022 | 28.84B | 218.00M | 0.76% |
| Mar 31, 2021 | 28.62B | -3.18B | -9.99% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Medius Holdings | 295.20B |
| JTEC Corporation | 2.01B |
| Daiken Medical | 10.17B |
| JMS Co.,Ltd. | 66.09B |
| KAINOS Laboratories | 4.44B |
| Shigematsu Works | 14.87B |
| ASO International | 3.95B |
| Medikit | 23.68B |